Our mission is to translate scientific advances into new treatments for people with Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Disease (MND) as rapidly as possible.
To achieve our goal, NEALS functions as an academic research consortium, a contracted research organization, and a resource tool for ALS community. Learn more about our structure.
The NEALS consortium is committed to the principles of open scientific communication, peer review, full and open disclosure of potential conflicts of interest, and democratic governance of its organization and activities.
NEALS was founded in 1995 with 9 academic clinical centers in the New England area. With help from The ALS Association's TREAT ALS Network, Muscular Dystrophy Association, and our generous donors, the NEALS membership has grown to over 130 research centers committed to performing research in ALS and MND.